| COVID-19 Vaccine |
1 |
1 |
| Transplantation |
0 |
0.9 |
| Liver Transplantation |
0 |
0.74 |
| Organ Transplantation |
0 |
0.95 |
| Vaccines |
0 |
0.7 |
| Lung Transplantation |
0 |
0.6 |
| Bone Marrow Transplant |
0 |
0.44 |
| HIV Infection |
0 |
0.44 |
| COVID-19 |
0 |
0.9 |
| Liver Disease |
0 |
0.37 |
| Liver |
0 |
0.35 |
| Fatty Liver |
0 |
0.29 |
| Hepatic Fibrosis |
0 |
0.29 |
| Hospital |
0 |
0.29 |
| Immunocompromise |
0 |
0.9 |
| Severe Acute Respiratory Syndrome (SARS) |
0 |
0.29 |
| Biliary Disease |
0 |
0.27 |
| Metabolic Syndrome |
0 |
0.27 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.27 |
| Acute Respiratory Distress Syndrome |
0 |
0.2 |
| Immunization |
0 |
0.17 |
| Dialysis |
0 |
0.7 |
| Bone Marrow |
0 |
0.08 |
| Hemodialysis |
0 |
0.08 |
| Antimetabolite |
0 |
0.06 |
| Antiviral Agents |
0 |
0.06 |
| Autoimmune Disease |
0 |
0.06 |
| Bone |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Food and Drug Administration (FDA) |
0 |
0.06 |
| Lung |
0 |
0.06 |
| T-Lymphocyte |
0 |
0.06 |
| Tennessee |
0 |
0.06 |